By , , (Reuters) - France and Germany have quit talks on reforming the World Health Organization in frustration at attempts by the United States to lead the negotiations, despite its decision to leave the WHO, three officials told Reuters.The move is a setback for President Donald Trump as Washington, which holds the rotating chair of the G7, had hoped to issue a common roadmap for a sweeping overhaul of the WHO in September, two months before the U.S. presidential election.The United States gave the WHO a year’s notice in July that it is leaving the U.N. agency - which was created to...…By , , (Reuters) - France and Germany have quit talks on reforming the World Health Organization in frustration at attempts by the United States to lead the negotiations, despite its decision to leave the WHO, three officials told Reuters.The move is a setback for President Donald Trump as Washington, which holds the rotating chair of the G7, had hoped to issue a common roadmap for a sweeping overhaul of the WHO in September, two months before the U.S. presidential election.The United States gave the WHO a year’s notice in July that it is leaving the U.N. agency - which was created to...WW…

By , , (Reuters) - France and Germany have quit talks on reforming the World Health Organization in frustration at attempts by the United States to lead the negotiations, despite its decision to leave the WHO, three officials told Reuters.The move is a setback for President Donald Trump as Washington, which holds the rotating chair of the G7, had hoped to issue a common roadmap for a sweeping overhaul of the WHO in September, two months before the U.S. presidential election.The United States gave the WHO a year’s notice in July that it is leaving the U.N. agency - which was created to...…By , , (Reuters) - France and Germany have quit talks on reforming the World Health Organization in frustration at attempts by the United States to lead the negotiations, despite its decision to leave the WHO, three officials told Reuters.The move is a setback for President Donald Trump as Washington, which holds the rotating chair of the G7, had hoped to issue a common roadmap for a sweeping overhaul of the WHO in September, two months before the U.S. presidential election.The United States gave the WHO a year’s notice in July that it is leaving the U.N. agency - which was created to...WW…

By BRUSSELS (Reuters) - Pfizer Inc has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, EU officials said, leaving it about one-third short of the supply it had expected from the U.S. drugmaker.The shortfall is another blow to the EU, which has also been hit by delays in vaccine deliveries from Britain-based AstraZeneca Plc and U.S. biotech Moderna Inc. It had also faced earlier delays with the shot from Pfizer.The situation raises questions about the rationale of an EU vaccine export control scheme set up in late January to ensure...…By BRUSSELS (Reuters) - Pfizer Inc has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, EU officials said, leaving it about one-third short of the supply it had expected from the U.S. drugmaker.The shortfall is another blow to the EU, which has also been hit by delays in vaccine deliveries from Britain-based AstraZeneca Plc and U.S. biotech Moderna Inc. It had also faced earlier delays with the shot from Pfizer.The situation raises questions about the rationale of an EU vaccine export control scheme set up in late January to ensure...WW…

By BRUSSELS (Reuters) - Pfizer Inc has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, EU officials said, leaving it about one-third short of the supply it had expected from the U.S. drugmaker.The shortfall is another blow to the EU, which has also been hit by delays in vaccine deliveries from Britain-based AstraZeneca Plc and U.S. biotech Moderna Inc. It had also faced earlier delays with the shot from Pfizer.The situation raises questions about the rationale of an EU vaccine export control scheme set up in late January to ensure...…By BRUSSELS (Reuters) - Pfizer Inc has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, EU officials said, leaving it about one-third short of the supply it had expected from the U.S. drugmaker.The shortfall is another blow to the EU, which has also been hit by delays in vaccine deliveries from Britain-based AstraZeneca Plc and U.S. biotech Moderna Inc. It had also faced earlier delays with the shot from Pfizer.The situation raises questions about the rationale of an EU vaccine export control scheme set up in late January to ensure...WW…

By , BRUSSELS (Reuters) - AstraZeneca has offered to bring forward some deliveries of its COVID-19 vaccine to the European Union while the bloc has asked the British drugmaker if it can divert doses from the UK to make up for a shortfall in supplies, European officials told Reuters.The Anglo-Swedish company unexpectedly announced on Friday it would cut supplies to the EU of its vaccine candidate in the first quarter of this year, a move that a senior EU official told Reuters meant a 60% reduction to 31 million doses for the bloc.That complicated the EU’s vaccination plans, after Pfizer had...…By , BRUSSELS (Reuters) - AstraZeneca has offered to bring forward some deliveries of its COVID-19 vaccine to the European Union while the bloc has asked the British drugmaker if it can divert doses from the UK to make up for a shortfall in supplies, European officials told Reuters.The Anglo-Swedish company unexpectedly announced on Friday it would cut supplies to the EU of its vaccine candidate in the first quarter of this year, a move that a senior EU official told Reuters meant a 60% reduction to 31 million doses for the bloc.That complicated the EU’s vaccination plans, after Pfizer had...WW…

By , BRUSSELS/FRANKFURT (Reuters) - The EU’s campaign to vaccinate Europeans against COVID-19 has got off to an uneven start in what will be a marathon effort to administer shots to enough of the bloc’s 450 million people to defeat the viral pandemic.In one mishap, eight workers at a care home in Stralsund on the north German coast were injected with five times the recommended dose of the vaccine developed by Pfizer and BioNTech. Four were hospitalised.“I deeply regret the incident. This individual case is due to individual errors. I hope that all those affected do not experience any...…By , BRUSSELS/FRANKFURT (Reuters) - The EU’s campaign to vaccinate Europeans against COVID-19 has got off to an uneven start in what will be a marathon effort to administer shots to enough of the bloc’s 450 million people to defeat the viral pandemic.In one mishap, eight workers at a care home in Stralsund on the north German coast were injected with five times the recommended dose of the vaccine developed by Pfizer and BioNTech. Four were hospitalised.“I deeply regret the incident. This individual case is due to individual errors. I hope that all those affected do not experience any...WW…

By BRUSSELS (Reuters) - The European Union criticised Britain’s rapid approval of Pfizer and BioNTech’s COVID-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a COVID-19 shot.The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU and faced criticism for his handling of the pandemic.The decision was made under an ultra-fast, emergency approval process, which allowed the British...…By BRUSSELS (Reuters) - The European Union criticised Britain’s rapid approval of Pfizer and BioNTech’s COVID-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a COVID-19 shot.The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU and faced criticism for his handling of the pandemic.The decision was made under an ultra-fast, emergency approval process, which allowed the British...WW…

By BRUSSELS (Reuters) - The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters.The bloc has agreed to pay 15.50 euros ($18.34) per dose for the COVID-19 vaccine candidate being developed by Pfizer and BioNTech, according to the official.That would mean an overall price of up to 3.1 billion euros ($3.7 billion) for 200 million doses, rising to 4.65 billion euros if another optional 100 million doses are purchased under the deal, the...…By BRUSSELS (Reuters) - The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters.The bloc has agreed to pay 15.50 euros ($18.34) per dose for the COVID-19 vaccine candidate being developed by Pfizer and BioNTech, according to the official.That would mean an overall price of up to 3.1 billion euros ($3.7 billion) for 200 million doses, rising to 4.65 billion euros if another optional 100 million doses are purchased under the deal, the...WW…

By Remdesivir, also known as Veklury, and steroid dexamethasone are the only drugs authorised to treat COVID-19 patients across the world. But the largest study on remdesivir’s efficacy, run by the World Health Organization (WHO), showed on Oct. 15 it had little or no impact, contradicting previous trials.In light of the new interim data from the WHO’s Solidarity trial “remdesivir is now classified as a drug you should not use routinely in COVID-19 patients,” the President of the European Society of Intensive Care Medicine (ESICM), Jozef Kesecioglu, said in an interview with...…By Remdesivir, also known as Veklury, and steroid dexamethasone are the only drugs authorised to treat COVID-19 patients across the world. But the largest study on remdesivir’s efficacy, run by the World Health Organization (WHO), showed on Oct. 15 it had little or no impact, contradicting previous trials.In light of the new interim data from the WHO’s Solidarity trial “remdesivir is now classified as a drug you should not use routinely in COVID-19 patients,” the President of the European Society of Intensive Care Medicine (ESICM), Jozef Kesecioglu, said in an interview with...WW…

By Remdesivir, also known as Veklury, and steroid dexamethasone are the only drugs authorised to treat COVID-19 patients across the world. But the largest study on remdesivir’s efficacy, run by the World Health Organization (WHO), showed on Oct. 15 it had little or no impact, contradicting previous trials.In light of the new interim data from the WHO’s Solidarity trial “remdesivir is now classified as a drug you should not use routinely in COVID-19 patients,” the President of the European Society of Intensive Care Medicine (ESICM), Jozef Kesecioglu, said in an interview with...…By Remdesivir, also known as Veklury, and steroid dexamethasone are the only drugs authorised to treat COVID-19 patients across the world. But the largest study on remdesivir’s efficacy, run by the World Health Organization (WHO), showed on Oct. 15 it had little or no impact, contradicting previous trials.In light of the new interim data from the WHO’s Solidarity trial “remdesivir is now classified as a drug you should not use routinely in COVID-19 patients,” the President of the European Society of Intensive Care Medicine (ESICM), Jozef Kesecioglu, said in an interview with...WW…